DUOX2 and inflammatory bowel disease: The experimental data revealed good discrimination for DUOX2, LCN2, and DEFA6 between normal individuals and IBD patients and poor discrimination for LOC389023 between normal individuals and IBD patients (P = 0.114) (Fig. 10).